Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis

Chembiochem. 2022 Dec 16;23(24):e202200551. doi: 10.1002/cbic.202200551. Epub 2022 Nov 22.

Abstract

The l-tryptophan decarboxylase PsiD catalyzes the initial step of the metabolic cascade to psilocybin, the major indoleethylamine natural product of the "magic" mushrooms and a candidate drug against major depressive disorder. Unlike numerous pyridoxal phosphate (PLP)-dependent decarboxylases for natural product biosyntheses, PsiD is PLP-independent and resembles type II phosphatidylserine decarboxylases. Here, we report on the in vitro biochemical characterization of Psilocybe cubensis PsiD along with in silico modeling of the PsiD structure. A non-canonical serine protease triad for autocatalytic cleavage of the pro-protein was predicted and experimentally verified by site-directed mutagenesis.

Keywords: biosynthesis; decarboxylases; enzymes; psilocybin; tryptophan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products*
  • Carboxy-Lyases* / genetics
  • Depressive Disorder, Major*
  • Humans
  • Psilocybin
  • Pyridoxal Phosphate

Substances

  • Psilocybin
  • Carboxy-Lyases
  • Biological Products
  • Pyridoxal Phosphate